There were 156 press releases posted in the last 24 hours and 167,922 in the last 365 days.

MOCON Reports First Quarter 2017 Results

MINNEAPOLIS, May 10, 2017 (GLOBE NEWSWIRE) -- MOCON, Inc. (NASDAQ:MOCO), today reported financial results for the first quarter ended March 31, 2017.

First Quarter 2017 Revenue and Earnings Summary

First quarter 2017 results compared to first quarter 2016:

  • Revenue increased five percent. The euro declined by three percent year-over-year which negatively impacted our overall growth rate by two percentage points. 
  • Revenue from foreign customers accounted for 66 percent for 2017 compared to 68 percent in 2016
  • Operating income was $0.8 million, or five percent of revenue for both 2017 and 2016
  • Net loss was $27,000, or $0.00 per share, compared to a net income of $0.5 million, or $0.08 per diluted share
  • Adjusted EBITDA was $1.7 million, or 11 percent of revenue, compared to $1.6 million, or 11 percent of revenue (See reconciliation to non-GAAP information below)

Revenue and Gross Margin by Segment ($ in thousands)


    Three Months Ended March 31,  
    Revenue     Gross Margin as a % of Revenue  
      2017     2016   Growth %     2017    2016   
Package Testing   $    7,436   $    7,002   6 %     59 %   58 %  
Permeation       5,583       5,283   6 %     58 %   57 %  
Industrial Analyzers and Other   2,477     2,445   1 %     43 %   44 %  
Total Revenue   $    15,496   $    14,730   5 %     56 %   55 %  

/EIN News/ -- Revenue from the Package Testing segment for the first quarter ended March 31, 2017 increased 6 percent due primarily to continued growth in demand for our products in the US and Europe. The euro declined by three percent year-over-year which negatively impacted our Pakage Testing segment’s growth rate by three percentage points. 

Revenue for the Permeation segment for the first quarter ended March 31, 2017 increased by 6 percent compared to the year-ago quarter.  The Permeation segment growth is attributable to an increase in domestic sales for instruments. The year-over-year euro decline mentioned above negatively impacted our Permeation segment’s growth rate by one percentage point. 

The Industrial Analyzers and Other segment increased by one percent for the first quarter ended March 31, 2017 compared to the year-ago quarter. The increase was driven by an increase in BevAlert instruments and sensors which was offset by a decrease in microbial detection products.

Gross Profit, Operating Income and Operating Expense Commentary

For the three-months ended March 31, 2017 gross profit was 56 percent up from 55 percent of revenue in the same period in 2016, driven by volume based efficiencies realized in our Permeation and Package Testing segments. 

Selling, general and administrative expenses were $6.5 million, or 42 percent of revenue, for the first quarter ended March 31, 2017 compared to $6.1 million, or 42 percent of revenue, in the year-ago quarter.  We incurred approximately $0.3 million in expenses during the first quarter of 2017 related to the recently announced merger agreement with AMETEK.  Research and development expenses were nine percent of revenue in the first quarter 2017, compared to eight percent in the year-ago quarter which is higher than our targeted spending targets of 6 to 8 percent of revenue and was driven by product development for OEM products. 

Overall, operating income was five percent of revenue in both of the first quarters ended March 31, 2017 and 2016.  

Income Tax Expense and Net Loss Commentary

Tax expense was 103 percent of income before income taxes, or $0.8 million, for the first quarter ended March 31, 2017 compared to 33 percent, or $0.2 million, for the first quarter ended March 31, 2017.  The increase in the effective tax rate is due to discrete events occurring during the three months ended March 31, 2017 related to the transaction costs incurred and additional reserves for uncertain tax positions.  Net loss was $27,000, or $0.00 per fully diluted share,  in the first quarter of 2017 and net income was $0.5 million, or $0.08 per diluted share, in the first quarter of 2016.

Balance Sheet and Cash Flow Summary

  • Cash and cash equivalents increased to $11.2 million at March 31, 2016 compared to $8.3 million at December 31, 2016.
  • Days sales outstanding were 61 in the first quarter of 2017 compared to 57 in the fourth quarter of 2016.
  • Total debt was $1.3 million at March 31, 2017 compared to $0.2 million at and December 31, 2016.


MOCON is a leading provider of detectors, instruments, systems and consulting services to research laboratories, production facilities, and quality control and safety departments in the medical, pharmaceutical, food and beverage, packaging, environmental, oil and gas and other industries worldwide.  See for more information.

Use of Non-GAAP Financial Measures

MOCON supplements its financial statements to provide investors with earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA plus share-based compensation, gain on sale of business, realignment expenses, and foreign currency transactional losses (“Adjusted EBITDA”), which are not calculated in accordance with general accepted accounting principles (“GAAP”) in the United States of America.

MOCON believes that these non-GAAP measures provide useful information to the company’s Board of Directors, management and investors regarding certain trends relating to its financial condition and operating performance. MOCON’s management uses these non-GAAP measures to compare the company's performance to that of prior periods for trend analyses and planning purposes

The method MOCON uses to produce non-GAAP results is not computed according to GAAP, is likely to differ from the methods used by other companies and should not be regarded as a replacement for corresponding GAAP measures. MOCON urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.

Safe Harbor

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include statements that can be identified by words such as “will,” “may,” “expect,” “believe,” “anticipate,” “estimate,” “continue,” “planned”, or other similar expressions.  All forward-looking statements speak only as of the date of this press release.  MOCON undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.  In addition to the risks and uncertainties of ordinary business operations and conditions in the general economy and the markets in which the company competes, there are important factors that could cause actual results to differ materially from those anticipated by the forward-looking statements made in this press release.  These factors include, but are not limited to, impact of MOCON’s pending merger with AMETEK, including uncertainties as to if or when the closing of the merger may occur and the effects of disruption from the announcement of the entry into the merger agreement; MOCON’s ability to realize the cost savings associated with the realignment plan that was begun in 2015, fluctuations in foreign currency exchange rates, the terms of MOCON’s credit agreement including financial covenants included therein,  dependence on certain key industries, pricing and lack of availability of raw materials, crude oil pricing impact on oil exploration activities, and other factors set forth in the company’s Annual Report on Form 10-K for the year ended December 31, 2016 and other documents MOCON files with or furnishes to the Securities and Exchange Commission.

MOCON's shares are traded on the NASDAQ Global Market System under the symbol MOCO.
MOCON is a registered trademark of MOCON, Inc.; other trademarks are those of their respective holders.

(in Thousands, Except Per Share Data)
  Quarters Ended March 31,
    2017       2016  
Products $    12,345     $    11,384  
Services     2,726         2,812  
Consulting   425       534  
Total revenue   15,496       14,730  
Cost of revenue      
Products   5,272       4,970  
Services   1,137       1,174  
Consulting   423       482  
Total cost of revenue   6,832       6,626  
  Gross profit   8,664       8,104  
Selling, general and administrative expenses   6,488       6,138  
Research and development expenses     1,358         1,203  
  Operating income    818       763  
Other expense, net   (40 )     (35 )
  Income before income taxes     778         728  
Income tax expense     805         240  
  Net income (loss) $    (27 )   $    488  
Net income (loss) per common share:      
  Basic $   -     $ 0.08  
  Diluted $   -     $ 0.08  
Weighted average common shares outstanding:      
  Basic   5,856       5,797  
  Diluted   5,856       5,816  


  March 31, 2017   December 31, 2016  
  Cash and marketable securities $    11,162   $    8,313  
  Accounts receivable, net   10,443     10,726  
  Inventories   7,515     6,728  
  Other current assets   1,788     1,395  
  Total current assets   30,908     27,162  
  Property, plant and equipment, net   5,394     5,457  
  Goodwill, intangibles and other assets   15,412     15,829  
  Total assets $    51,714   $    48,448  
Liabilities and Shareholders’ Equity:        
  Notes payable, current $    82   $    83  
  Other current liabilities   13,013     10,632  
  Total noncurrent liabilities   2,421     1,282  
  Shareholders’ equity   36,198     36,451  
  Total liabilities and shareholders’ equity $    51,714   $    48,448  

CONDENSED CASH FLOW DATA: (unaudited) March 31, 2017   March 31, 2016
Net cash provided by operations $    3,056     $    93  
Net cash used in investing activities     (186 )       (102 )
Net cash provided by (used in) financing activities      695         (578 )
Effect of exchange rate changes     (716 )       205  
Net increase (decrease) in cash     2,849         (382 )
Cash beginning of period     8,313         6,344  
Cash end of period $    11,162     $    5,962  

(in Thousands)  
  Quarter Ended March 31,  
    2017       2016    
Net income (loss) $    (27 )   $    488    
Interest expense, net     -          26    
Income tax expense     805         240    
Depreciation and amortization     668         689    
EBITDA     1,446         1,443    
Share-based compensation     205         186    
Foreign currency transaction loss     37         9    
Adjusted EBITDA $    1,688     $    1,638    


MOCON, Inc. Company Contacts:

Elissa Lindsoe, CFO
763-493-6370 /
Steven Hooser, Investor Relations
Three Part Advisors, LLC
(214) 872-2710

Primary Logo